CoLucid Pharmaceuticals Relocates To Cambridge, Massachusetts, Region
03/24/2015
"We are very proud to have been a North Carolina-based company since our inception. However, given the expansion of our management team with Massachusetts-based executives, we feel it is the right time to relocate. Cambridge is the heart of the biotechnology industry and we are very excited to be a part of all the innovation and excitement that takes place here every day," said Thomas P. Mathers, CEO of CoLucid.
"We are thrilled to welcome CoLucid Pharmaceuticals to the Massachusetts life sciences community," said Robert K. Coughlin, President/CEO of MassBio, the Massachusetts life sciences trade association. "We know CoLucid will thrive in the ecosystem of innovation and collaboration here in the Commonwealth as they work to advance treatments for CNS disorders."
Project Announcements
Vietnam-Based Boviet Solar Plans Greenville, North Carolina, Production Operations
05/01/2024
Nestlé Purina PetCare Company Expands Jefferson, Wisconsin, Operations
04/30/2024
Honda Motor Plans Alliston, Ontario, Canada, EV Production-Battery Operations
04/30/2024
Toyota Expand Princeton, Indiana, Assembly Operations
04/30/2024
Tradd Advisory Company Expands Mount Pleasant, South Carolina, Operations
04/29/2024
KOI Superior Walls Plans Boone County, Kentucky, Operations
04/29/2024
Most Read
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
38th Annual Corporate Survey: Are Unrealized Predictions of an Economic Slump Leading Small to Mid-Size Companies to Put Off Expansion Plans?
Q1 2024
-
Making Hybrid More Human in 2024
Q1 2024
-
Manufacturing Momentum Is Building
Q1 2024
-
20th Annual Consultants Survey: Clients Prioritize Access to Skilled Labor, Responsive State & Local Government
Q1 2024
-
Public-Private Partnerships Incentivize Industrial Development
Q1 2024